XRAY vs NVST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

XRAY

58.9
AI Score
VS
XRAY Wins

NVST

45.1
AI Score

Investment Advisor Scores

XRAY

59score
Recommendation
HOLD

NVST

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XRAY NVST Winner
Revenue 1.78B 1.44B XRAY
Net Income 27.00M 92.40M NVST
Gross Margin 51.7% 55.5% NVST
Net Margin 1.5% 6.4% NVST
Operating Income 47.00M 142.80M NVST
ROE 2.0% 3.0% NVST
ROA 0.5% 1.7% NVST
Total Assets 5.20B 5.60B NVST
Cash 239.00M 1.13B NVST
Debt/Equity 1.48 0.47 NVST
Current Ratio 1.63 2.43 NVST

Relative Price Performance (Last 90 Days)

XRAY 1M: -15.8% · 3M: +6.7% NVST 1M: +3.8% · 3M: +16.7%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.1 · Price: $10.89

NVST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.7 · Price: $27.34

Fundamentals Snapshot

Metric XRAY NVST
Market Cap
Forward P/E 7.2 16.4
Trailing P/E 46.9
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin 0.1% 0.1%
EPS -2.73 0.58
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.